生存率-话题@MedSci

#生存率#

482篇内容 | 3107人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256565, encodeId=a62f1256565ab, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=白血病治疗疫苗年内将启动临床试验，5年生存率有望提高两成, objectType=article, longId=99149, objectId=febf991496a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=febf991496a, replyNumber=0, likeNumber=80, createdTime=2017-05-20, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=febf991496a, moduleTitle=白血病治疗疫苗年内将启动临床试验，5年生存率有望提高两成, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=febf991496a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256564, encodeId=ef0a125656412, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Neurol：突触核蛋白病患者生存率及死亡原因研究, objectType=article, longId=98956, objectId=1dd898956fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1dd898956fb, replyNumber=0, likeNumber=58, createdTime=2017-05-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1dd898956fb, moduleTitle=JAMA Neurol：突触核蛋白病患者生存率及死亡原因研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1dd898956fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256563, encodeId=95c61256563ef, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Aliment Pharmacol Ther：索拉非尼的毒性可预测肝癌患者生存率改善, objectType=article, longId=98558, objectId=f76f9855801, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f76f9855801, replyNumber=0, likeNumber=18, createdTime=2017-05-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f76f9855801, moduleTitle=Aliment Pharmacol Ther：索拉非尼的毒性可预测肝癌患者生存率改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f76f9855801)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256562, encodeId=df861256562d3, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet HIV：1996-2013HIV感染者生存率变化, objectType=article, longId=98511, objectId=fa279851151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa279851151, replyNumber=0, likeNumber=71, createdTime=2017-05-13, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa279851151, moduleTitle=Lancet HIV：1996-2013HIV感染者生存率变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa279851151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256561, encodeId=5705125656105, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Ann Oncol：贝伐珠单抗可显著提高卵巢癌患者生存率！, objectType=article, longId=98196, objectId=2ddb98196c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ddb98196c2, replyNumber=0, likeNumber=0, createdTime=2017-05-10, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ddb98196c2, moduleTitle=Ann Oncol：贝伐珠单抗可显著提高卵巢癌患者生存率！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ddb98196c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256560, encodeId=386d12565601c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet Oncol：贝伐单抗可提高铂化疗敏感的复发性卵巢癌患者生存率, objectType=article, longId=96885, objectId=7d279688506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d279688506, replyNumber=0, likeNumber=59, createdTime=2017-04-26, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d279688506, moduleTitle=Lancet Oncol：贝伐单抗可提高铂化疗敏感的复发性卵巢癌患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d279688506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256559, encodeId=7c1a1256559cc, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Sci Rep：对乳腺癌生存率的影响蔬菜和水果可能不太一样！, objectType=article, longId=96153, objectId=19829615397, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19829615397, replyNumber=0, likeNumber=58, createdTime=2017-04-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19829615397, moduleTitle=Sci Rep：对乳腺癌生存率的影响蔬菜和水果可能不太一样！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19829615397)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256558, encodeId=17d41256558f9, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Surg：黑色素瘤腹部转移的治疗与生存率：1969-2014, objectType=article, longId=95056, objectId=8d4e95056bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4e95056bf, replyNumber=0, likeNumber=62, createdTime=2017-04-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4e95056bf, moduleTitle=JAMA Surg：黑色素瘤腹部转移的治疗与生存率：1969-2014, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d4e95056bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256557, encodeId=6a3a125655efd, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=免疫药物Nivolumab治疗晚期肺癌，5年总生存率为16%, objectType=article, longId=94614, objectId=d6b79461428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6b79461428, replyNumber=0, likeNumber=55, createdTime=2017-04-06, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6b79461428, moduleTitle=免疫药物Nivolumab治疗晚期肺癌，5年总生存率为16%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6b79461428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256556, encodeId=cfae1256556aa, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=The Lancet Oncology：曲妥珠单抗不能提高HER2阳性晚期胃癌患者的生存率, objectType=article, longId=93205, objectId=fef993205fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fef993205fc, replyNumber=0, likeNumber=47, createdTime=2017-03-25, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fef993205fc, moduleTitle=The Lancet Oncology：曲妥珠单抗不能提高HER2阳性晚期胃癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fef993205fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256555, encodeId=84e6125655505, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Stroke：婚姻状况与卒中后生存率有啥关系？, objectType=article, longId=84559, objectId=edc2845592e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edc2845592e, replyNumber=0, likeNumber=74, createdTime=2016-12-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edc2845592e, moduleTitle=Stroke：婚姻状况与卒中后生存率有啥关系？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edc2845592e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256554, encodeId=d95312565540a, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Cancer：新发现！社交关系也会影响乳腺癌的生存率, objectType=article, longId=84347, objectId=8f738434ebe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f738434ebe, replyNumber=0, likeNumber=55, createdTime=2016-12-16, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f738434ebe, moduleTitle=Cancer：新发现！社交关系也会影响乳腺癌的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f738434ebe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256553, encodeId=36df12565537e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JCO：切除程度对COG A3973研究中高风险神经母细胞瘤患者的局部控制和生存率的影响, objectType=article, longId=83084, objectId=3519830843c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3519830843c, replyNumber=0, likeNumber=58, createdTime=2016-11-27, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3519830843c, moduleTitle=JCO：切除程度对COG A3973研究中高风险神经母细胞瘤患者的局部控制和生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3519830843c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256552, encodeId=f3ef12565529c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AHA 2016：旁观者CRP能提高院外心脏骤停患儿的生存率, objectType=article, longId=82320, objectId=227082320a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=227082320a7, replyNumber=0, likeNumber=68, createdTime=2016-11-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=227082320a7, moduleTitle=AHA 2016：旁观者CRP能提高院外心脏骤停患儿的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=227082320a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256551, encodeId=669e125655182, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Circ Heart Failure：他汀类药物可提高心脏移植者的生存率, objectType=article, longId=82296, objectId=b4ae8229639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b4ae8229639, replyNumber=0, likeNumber=112, createdTime=2016-11-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b4ae8229639, moduleTitle=Circ Heart Failure：他汀类药物可提高心脏移植者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b4ae8229639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256550, encodeId=414512565500d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA子刊：不产生AFP的肝癌患者，肝移植后复发率和生存率如何？, objectType=article, longId=79684, objectId=e6a7e968469, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6a7e968469, replyNumber=0, likeNumber=64, createdTime=2016-10-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6a7e968469, moduleTitle=JAMA子刊：不产生AFP的肝癌患者，肝移植后复发率和生存率如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6a7e968469)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256549, encodeId=20e0125654900, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Thorax：空气污染影响肺癌患者生存率, objectType=article, longId=79493, objectId=3483e949341, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3483e949341, replyNumber=0, likeNumber=59, createdTime=2016-10-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3483e949341, moduleTitle=Thorax：空气污染影响肺癌患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3483e949341)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256548, encodeId=1bac125654898, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Am J Kidney Dis：透析前心血管疾病用药依从性影响透析患者生存率, objectType=article, longId=79268, objectId=169be92685b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=169be92685b, replyNumber=0, likeNumber=47, createdTime=2016-10-07, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=169be92685b, moduleTitle=Am J Kidney Dis：透析前心血管疾病用药依从性影响透析患者生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=169be92685b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256547, encodeId=56eb125654e0f, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ASTRO 2016：立体定向放射治疗增加早期非小细胞肺癌患者的生存率, objectType=article, longId=78842, objectId=538ae8842d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=538ae8842d1, replyNumber=0, likeNumber=65, createdTime=2016-09-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=538ae8842d1, moduleTitle=ASTRO 2016：立体定向放射治疗增加早期非小细胞肺癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=538ae8842d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256546, encodeId=3b6d1256546ea, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J Clin Oncol：高危B-ALL患者来说，接受大剂量甲氨蝶呤治疗可更好地改善其生存率, objectType=article, longId=74192, objectId=da19e419235, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da19e419235, replyNumber=0, likeNumber=13, createdTime=2016-08-02, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da19e419235, moduleTitle=J Clin Oncol：高危B-ALL患者来说，接受大剂量甲氨蝶呤治疗可更好地改善其生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da19e419235)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

白血病治疗疫苗年内将启动临床试验，5年生存率有望提高两成

2017-05-20

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Neurol：突触核蛋白病患者生存率及死亡原因研究

2017-05-19

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Aliment Pharmacol Ther：索拉非尼的毒性可预测肝癌患者生存率改善

2017-05-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet HIV：1996-2013HIV感染者生存率变化

2017-05-13

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Ann Oncol：贝伐珠单抗可显著提高卵巢癌患者生存率！

2017-05-10

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet Oncol：贝伐单抗可提高铂化疗敏感的复发性卵巢癌患者生存率

2017-04-26

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Sci Rep：对乳腺癌生存率的影响蔬菜和水果可能不太一样！

2017-04-19

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Surg：黑色素瘤腹部转移的治疗与生存率：1969-2014

2017-04-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

免疫药物Nivolumab治疗晚期肺癌，5年总生存率为16%

2017-04-06

guoyibin (审核中...)

前往app查看评论内容

#生存率#

The Lancet Oncology：曲妥珠单抗不能提高HER2阳性晚期胃癌患者的生存率

2017-03-25

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Stroke：婚姻状况与卒中后生存率有啥关系？

2016-12-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Cancer：新发现！社交关系也会影响乳腺癌的生存率

2016-12-16

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JCO：切除程度对COG A3973研究中高风险神经母细胞瘤患者的局部控制和生存率的影响

2016-11-27

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AHA 2016：旁观者CRP能提高院外心脏骤停患儿的生存率

2016-11-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Circ Heart Failure：他汀类药物可提高心脏移植者的生存率

2016-11-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA子刊：不产生AFP的肝癌患者，肝移植后复发率和生存率如何？

2016-10-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Thorax：空气污染影响肺癌患者生存率

2016-10-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Am J Kidney Dis：透析前心血管疾病用药依从性影响透析患者生存率

2016-10-07

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ASTRO 2016：立体定向放射治疗增加早期非小细胞肺癌患者的生存率

2016-09-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J Clin Oncol：高危B-ALL患者来说，接受大剂量甲氨蝶呤治疗可更好地改善其生存率

2016-08-02

科室
- - 订阅+
  - 更多科室
工具
服务